Skip to main content
SpringerLink
Log in

Preventing and Managing Renal Disease in Diabetes

  • Chapter
  • First Online:
Diabetes Management in Clinical Practice

  • 1994 Accesses

Abstract

Diabetic nephropathy is the leading cause of end stage renal disease worldwide. The current epidemic of type 2 diabetes (T2D) will lead to further increase in the prevalence of this condition.

In this chapter we review the pathology of diabetic nephropathy in patients with type 1 diabetes (T1D) and T2D. The staging according to presence of albuminuria and chronic kidney disease (CKD) classification is also discussed. We outline the principles of annual screening, investigation and management of patients with diabetes at risk of nephropathy, patients with microalbuminuira and also those with established diabetic nephropathy. The need for preventative therapy including blood glucose and blood pressure control is addressed, and we discuss the importance of ACE inhibitors and angiotensin-2 receptor blockers in the management of these patients. The importance of cardiovascular risk factor management is also highlighted.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Key References

  • Adler AL, Stevens RJ, Manly SE, et al. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int. 2003;63:225–32.

    Article  PubMed  Google Scholar 

  • ADVANCE Collaborative Group. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet. 2007;370:829–40.

    Article  Google Scholar 

  • Barnett AH, Bain SC, Bouter P, et al. Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy. N Engl J Med. 2004;351:1952–61.

    Article  CAS  PubMed  Google Scholar 

  • Chan JC, Ko GT, Leung DH, et al. Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive T2DM patients. Kidney Int. 2000;57:590–600.

    Article  CAS  PubMed  Google Scholar 

  • de Boer IH, Sun W, Cleary PA, et al., DCCT/EDIC Research Group. Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes. N Engl J Med. 2011;365:2366.

    Google Scholar 

  • Gaede P, Vedel P, Larsen N, et al. Effect of a multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348:383–593.

    Article  PubMed  Google Scholar 

  • Gaede P, Lund-Andersen H, Parving HH, et al. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358:580–91.

    Article  CAS  PubMed  Google Scholar 

  • Gall MA, Hougaard P, Johnsen KB, Parving HH. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study. BMJ. 1997;314:783–8.

    Article  CAS  PubMed  Google Scholar 

  • Holman RR, Paul SK, Bethel MA, et al. 10 years follow up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577.

    Article  CAS  PubMed  Google Scholar 

  • Hovind P, Tarnow L, Rossing P, et al. Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study. BMJ (Clinical research ed). 2004;328(7448):1105.

    Article  Google Scholar 

  • Ismail-Beigi F, Craven T, Banerji MA, et al. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet. 2010;376:419.

    Article  PubMed  Google Scholar 

  • Joint Speciality Committee on Renal Medicine of the Royal College of Physicians and the Renal Association, and the Royal College of General Practitioners. Chronic kidney disease in adults: UK guidelines for identification, management and referral. London: Royal College of Physicians; 2006. Last accessed on 9 June 2012.

    Google Scholar 

  • Krolewski AS, Laffel LMB, Krolewski M, et al. Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med. 1995;332(19):1251–5.

    Article  CAS  PubMed  Google Scholar 

  • Microalbuminuria Collaborative Study Group United Kingdom. Intensive therapy and progression to clinical albuminuria in patients with insulin dependent diabetes mellitus and microalbuminuria. BMJ. 1995;311:973–7.

    Google Scholar 

  • Mogensen CE, Christensen CK, Vittinghus E. The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy. Diabetes. 1983;32 Suppl 2:64–78.

    Article  PubMed  Google Scholar 

  • National Kidney Foundation. KDOQI clinical practice guidelines for diabetes and CKD:2012 Update. Available at http://www.kidney.org/professionals/KDOQI/guidelines_diabetesUp/diabetes-ckd-update-2012.pdf. Last accesses 10 June 2013.

  • Parving HH, Lehnert H, Brochner-Mortensen J, et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med. 2001;345:870–8.

    Article  CAS  PubMed  Google Scholar 

  • The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–86.

    Google Scholar 

  • The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet. 2000;355:253–9.

    Article  Google Scholar 

  • The Microalbuminuria Collaborative Group. Predictors of the development of microalbuminuria in patients with type 1 diabetes mellitus: a seven-year prospective study. Diabet Med. 1999;16(11):918–25.

    Article  Google Scholar 

  • The National Institute for Health and Clinical Excellence. Hypertension, clinical management of primary hypertension. NICE CG 127. Available at http://www.bhsoc.org/latest_bhs_management_guidelines. Last accessed 2 Sept 2012.

  • UK Prospective Diabetes Study (UKPDS) Group: Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. (UKPDS 33). Lancet. 1998;352:837–53.

    Google Scholar 

  • UK Renal Registry: 14th annual report: December 2011. Available at www.renalreg.com/reports/2011. Last accessed 2 Sept 2011.

Download references

Author information

Authors and Affiliations

  1. Diabetes, Singleton Hospital, Swansea, South Wales, UK

    Richard A. Chudleigh MD, MRCP & Pranav Kumar MRCP

  2. Diabetes, Singleton Hospital and Institute of Life Science, Swansea, South Wales, UK

    Stephen C. Bain MA, MD, FRCP

Authors
  1. Richard A. Chudleigh MD, MRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pranav Kumar MRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stephen C. Bain MA, MD, FRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stephen C. Bain MA, MD, FRCP .

Editor information

Editors and Affiliations

  1. The Royal London Hospital, London, United Kingdom

    Tahseen A. Chowdhury

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag London

About this chapter

Cite this chapter

Chudleigh, R.A., Kumar, P., Bain, S.C. (2014). Preventing and Managing Renal Disease in Diabetes. In: Chowdhury, T. (eds) Diabetes Management in Clinical Practice. Springer, London. https://doi.org/10.1007/978-1-4471-4869-2_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-4869-2_4

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-4868-5

  • Online ISBN: 978-1-4471-4869-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation